Westlake Chemical Corporation - Form 8-K Summary
Business Context and Reporting Period
Westlake Chemical Corporation (Westlake) filed this Current Report on Form 8-K on September 16, 2011. The filing discloses the entry into a material definitive agreement regarding the company's senior secured revolving credit facility.
Key Financial Metrics and Debt Structure
The filing details a $400 million senior secured revolving credit facility. Key terms include:
- Facility Size: $400 million total commitment.
- Maturity Date: Extended from September 8, 2013, to September 16, 2016.
- Interest Rates: LIBOR plus 1.75% to 2.25% or Base Rate plus 0.25% to 0.75%, subject to monthly grid pricing adjustments.
- Fees: Unused commitment fee of 0.375%.
- Letters of Credit: $400 million sub-limit.
- Inventory Advances: Limited to $325 million.
- Expansion Option: Borrowers may increase the facility size up to four times in increments of at least $25 million (maximum increase of $150 million) subject to lender agreement.
Material Changes and Covenants
The Second Amendment and Restatement of the Credit Agreement introduces several material changes to borrowing capacity and restrictions:
- Cost Reduction: Reduced interest rates and facility fees compared to the prior agreement.
- Fixed Charge Coverage Ratio: A covenant requires maintaining a minimum ratio of 1.0:1.0 for successive 30-day periods if borrowing availability falls below the greater of 12.5% of commitments or $50 million.
- Distribution Restrictions: Distributions are generally restricted unless borrowing availability exceeds the greater of 25% of commitments or $100 million. An exception allows up to $25 million in aggregate distributions if availability exceeds the greater of 17.5% of commitments or $70 million, or if the fixed charge coverage ratio is at least 1.0:1.0.
- Acquisition and Investment Limits: Similar restrictions apply to acquisitions and investments, with a $25 million aggregate exception under specific availability or coverage ratio conditions.
- Specific Investment Exceptions: The company is permitted to invest up to $200 million in joint ventures owning feedstock, raw material, and ethylene pipeline/storage facilities, and up to $55 million in Suzhou Huasu Plastics Co., Ltd.
- Debt Capacity: Allows up to $150 million in purchase money debt and eliminates the $20 million cap on capital leases. Debt secured by liens on non-collateral assets is permitted up to the greater of $600 million or 30% of tangible assets.
- Sale and Leaseback: Transactions up to $150 million are permitted.
- Prepayment: Allows prepayment of debt with unrestricted cash and existing senior notes with unrestricted or restricted cash, provided no default exists.
Guidance, Outlook, and Risks
The filing does not provide specific financial guidance, revenue outlook, or management commentary regarding future earnings. The primary risk disclosed relates to compliance with the new financial covenants, specifically the fixed charge coverage ratio and borrowing availability thresholds required to maintain flexibility for distributions and acquisitions. The filing notes that the summary is qualified in its entirety by reference to the full Amendment and Restatement.
Key Facts for Investor Verification
- Verify the current borrowing availability under the $400 million facility to assess compliance with the new distribution and acquisition covenants.
- Confirm the company's current fixed charge coverage ratio to ensure it meets the 1.0:1.0 threshold required for certain financial flexibilities.
- Review the specific terms of the $200 million joint venture investment allowance and the $55 million Suzhou Huasu Plastics investment to understand capital allocation priorities.
- Monitor the unused commitment fee impact (0.375%) on the company's cost of capital given the extended maturity date.
- Check for any subsequent filings regarding the utilization of the facility expansion option (up to $150 million).